Home / CYP1B1 Knockout Cell Lines

CYP1B1 Knockout Cell Lines

Gene: CYP1B1

Official Full Name: cytochrome P450 family 1 subfamily B member 1provided by HGNC

Gene Summary: This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO06277 CYP1B1 Knockout cell line (HeLa) Human CYP1B1 1:3~1:6 Negative Online Inquiry
KO06278 CYP1B1 Knockout cell line (HCT 116) Human CYP1B1 1:2~1:4 Negative Online Inquiry
KO06279 CYP1B1 Knockout cell line (HEK293) Human CYP1B1 1:3~1:6 Negative Online Inquiry
KO06280 CYP1B1 Knockout cell line (A549) Human CYP1B1 1:3~1:4 Negative Online Inquiry

Background

CYP1B1 Gene Knockout Cell Lines refer to genetically engineered cell lines in which the CYP1B1 gene has been inactivated or "knocked out." The CYP1B1 gene encodes an enzyme involved in the metabolism of various endogenous and exogenous compounds, including certain carcinogens and drugs. By creating knockout versions of these cell lines, researchers have an invaluable tool to study the functional consequences of CYP1B1 deficiency on cell behavior and pharmacological response.

These cell lines operate by utilizing CRISPR-Cas9 or other gene-editing technologies to disrupt the genomic sequence of the CYP1B1 gene, thereby preventing the expression of its protein product. This allows for the investigation of metabolic pathways and cellular processes that are influenced by CYP1B1, providing insights into its role in drug metabolism, developmental biology, and cancer research.

The scientific importance of CYP1B1 Gene Knockout Cell Lines lies in their ability to aid in understanding diseases associated with dysregulated metabolism, such as various cancers and cardiovascular diseases. In clinical research, these cell lines can serve as valuable models for drug efficacy studies and toxicity testing, allowing scientists to explore how CYP1B1 alterations influence therapeutic outcomes and side effects.

Compared to traditional cell lines, the unique selling points of these knockout models include their specificity, enhanced reproducibility, and broader applicability in translational research. They facilitate more accurate modeling of in vivo conditions, leading to potentially higher translational success rates in clinical settings.

For researchers and clinicians looking to expand their understanding of metabolic pathways or improve drug development processes, CYP1B1 Gene Knockout Cell Lines offer an exceptional resource. The ability to investigate the ramifications of gene knockout at a cellular level enhances experimental designs and outcomes.

Our company specializes in providing high-quality genetic tools and resources, bolstered by an extensive background in molecular biology. Our expertise guarantees that you receive reliable, precise, and validated cell lines to support your research and development efforts effectively.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.